LSV Associates LLC 13D and 13G filings for ALX Oncology Holdings Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 7:28 pm Sale |
2023-12-15 | 13D | ALX Oncology Holdings Inc. ALXO |
LSV Associates LLC | 2,949,580 5.900% |
-1,259,395 (-29.92%) |
Filing |
| 2023-12-19 5:38 pm Sale |
2023-12-13 | 13D | ALX Oncology Holdings Inc. ALXO |
LSV Associates LLC | 4,208,975 8.400% |
-512,015 (-10.85%) |
Filing |
| 2020-07-30 9:53 pm Purchase |
2020-07-21 | 13D | ALX Oncology Holdings Inc. ALXO |
LSV Associates LLC | 4,720,990 12.900% |
4,720,990 (New Position) |
Filing |